rs199472986
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000238.4(KCNH2):c.2162C>T(p.Pro721Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.2162C>T | p.Pro721Leu | missense_variant | Exon 9 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 37
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Congenital long QT syndrome Pathogenic:1Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476;PMID:19841300). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Variant summary: The variant, KCNH2 c.2162C>T (p.Pro721Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 36208 control chromosomes (gnomAD) and has been reported in the literature in individuals affected with Long-QT syndrome (Giudicessi_2012, Itoh_2016, Kapa_2009). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and state that the missense change leads to a trafficking deficient protein which cannot be corrected in their in vitro studies (Anderson _2014). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Long QT syndrome Pathogenic:1
In summary, this variant is absent from population databases, has been observed in at least one patient with long QT syndrome, and has been shown to have a deleterious functional effect. In the absence of confirmed segregation evidence, at this time this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change leads to a trafficking-deficient KCNH2 protein that is unable to be corrected in vitro (PMID: 25417810). This variant is not present in population databases (rs199472986, ExAC no frequency). This variant has been reported in at least one individual affected with long QT syndrome (PMID: 15840476, 19841300, 22949429, 26669661). ClinVar contains an entry for this variant (Variation ID: 67371). This sequence change replaces proline with leucine at codon 721 of the KCNH2 protein (p.Pro721Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at